Trial intelligence / Profile preview

Myogenic Oscillations Pilot Study

NCT03719001Phase 1Completed

Sponsor
University of California, San Francisco
Start
Oct 2018
Primary completion
Jun 2022
Countries
1
01

Overview

Phase 1, open-label trial (6 arms), sponsored by University of California, San Francisco. Primary endpoint: Amplitude and/or frequency of myogenic oscillations up to 5 minutes. Started Oct 2018; status: completed.

Beyond the preview

Go deeper on NCT03719001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03719001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call